“Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement” (2026) SKIN The Journal of Cutaneous Medicine, 10(2), p. s726. doi:10.25251/mjfdzc48.